Nuvo Research provides a PENNSAID® franchise update – Sacramento Bee

PENNSAID (diclofenac sodium topical solution) 1.5% w/w U.S. Patent The United States Patent Office has issued Patent # 8,217,078 relating to a method of using PENNSAID (PENNSAID Patent).  The PENNSAID Patent expiry date is July 10, 2029.

Leave a Reply

Your email address will not be published.